David A. Bryce

Randomized Clinical Trial of an Implantable Drug Delivery System Compared With Comprehensive Medical Management for Refractory Cancer Pain: Impact on Pain, Drug-Related Toxicity, and Survival

Thomas J. Smith, Peter S. Staats, Timothy R. Deer et al. · Journal of Clinical Oncology · 2002 · 715 citations

Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS

Peter S. Staats, Thomas Yearwood, Steven G. Charapata et al. · JAMA · 2004 · 637 citations

An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations.

Laxmaiah Manchikanti, Salahadin Abdi, Sairam Atluri et al. · PubMed · 2013 · 311 citations

American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.

Laxmaiah Manchikanti, Salahadin Abdi, Sairam Atluri et al. · PubMed · 2012 · 245 citations

An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)

Thomas J. Smith, Patrick J. Coyne, Peter S. Staats et al. · Annals of Oncology · 2005 · 189 citations · Full text

Pain Therapy, Pain Research, Health Sciences +12